Variant report
Variant | esv2762560 |
---|---|
Chromosome Location | chr2:50597915-50605863 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1915174 | chr2:50597915-50597916 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs539669201 | chr2:50597916-50597917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557815269 | chr2:50597917-50597918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150100820 | chr2:50597923-50597924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542811805 | chr2:50597969-50597970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540212298 | chr2:50597972-50597973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78625801 | chr2:50597980-50597981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115685885 | chr2:50597990-50597991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75976120 | chr2:50598005-50598006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573680790 | chr2:50598035-50598036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192565624 | chr2:50598045-50598046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs5831116 | chr2:50598109-50598110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184818789 | chr2:50598113-50598114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146766375 | chr2:50598116-50598117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545091046 | chr2:50598129-50598130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367984774 | chr2:50598134-50598135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577884029 | chr2:50598135-50598136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368130798 | chr2:50598145-50598146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187679923 | chr2:50598177-50598178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192805979 | chr2:50598178-50598179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564595246 | chr2:50598183-50598184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528625295 | chr2:50598186-50598187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12465784 | chr2:50598187-50598188 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs561894634 | chr2:50598190-50598191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565246652 | chr2:50598192-50598193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112640054 | chr2:50598237-50598238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550836953 | chr2:50598247-50598248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569241479 | chr2:50598255-50598256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539633284 | chr2:50598257-50598258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551725923 | chr2:50598285-50598286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184308736 | chr2:50598290-50598291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533603055 | chr2:50598302-50598303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12465806 | chr2:50598327-50598328 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs573644036 | chr2:50598361-50598362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370094692 | chr2:50598378-50598379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547529410 | chr2:50598380-50598381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76195894 | chr2:50598418-50598419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115241705 | chr2:50598419-50598420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545185062 | chr2:50598420-50598421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550363630 | chr2:50598424-50598425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189872094 | chr2:50598585-50598586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191510488 | chr2:50599853-50599854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531956647 | chr2:50599854-50599855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577066524 | chr2:50599873-50599874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17531335 | chr2:50599937-50599938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs571345124 | chr2:50599941-50599942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540463375 | chr2:50600063-50600064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527630454 | chr2:50600112-50600113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531994466 | chr2:50600142-50600143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547407963 | chr2:50600155-50600156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 20531469 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50597400-50598600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr2:50598200-50598600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:50599800-50600200 | Enhancers | Pancreatic Islets | Pancreatic Islet |